AI controls, research access and an orbital TPU close out the weekend

OpenAI limits GPT-6 Rosalind Research to approved research users

OpenAI said on October 30 that it is rolling out GPT-6 Rosalind Research, a life-sciences model aimed at multistep research, to a limited set of approved Research customers in Work, Codex and the API. The company says the model includes safeguards for biological work; it is not available in ChatGPT’s Chat tab.

Access has two layers. An organization needs Rosalind Research approval, and users must be authorized within that organization. OpenAI says a separate Discovery approval is not enough, while Enterprise workspaces receive a two-week, off-by-default administrator preview. That makes this a controlled-access release rather than evidence that the system is ready for general scientific or clinical use.

The release notes name the API model as gpt-6-rosalind and say that GPT-5.5 Rosalind Research remains available. OpenAI did not use the announcement to report independent validation results, so prospective users still need to assess the model against their own scientific, privacy and compliance requirements.

Google makes Gemini Computer Use generally available

Google made its Computer Use tool generally available across the Gemini Interactions and GenerateContent APIs on October 30. The tool is intended to let a model act through browser and user-interface workflows, moving a category of agentic capability from preview into a production API surface.

General availability changes the support status, not the underlying safety problem. A system that can operate interfaces may encounter prompt injection, confusing task boundaries or consequential actions on behalf of a user. Google’s changelog does not establish that every use case is safe to automate, so teams still need permissions, confirmation points and testing around the systems the agent can reach.

Major providers propose a shared training-preference signal

OpenAI, Google and Microsoft each announced support for a common way for sites to express AI-training preferences in robots.txt. The proposal is intended to reduce the need for publishers to maintain separate crawler rules for each provider.

The practical details remain provider-specific and forward-looking. OpenAI says it aims to implement the signal in the coming months. Google says it plans to interpret the shared opt-out as a Google-Extended disallow when a site has not separately specified Google-Extended, while keeping its existing controls. Microsoft says it will begin honoring the new preferences on February 1, 2027. The announcements describe a voluntary mechanism under IETF-related standardization work, not a universal or immediately active opt-out.

Google reports an initial TPU inference result in orbit

Google said its Project Suncatcher prototype satellite returned what it called the first AI response from a data-center-class TPU in orbit. According to the company, a ground station sent a prompt to an onboard Gemma 4 open model, which generated a haiku that was returned during a pass near Svalbard, Norway.

The experiment is an early infrastructure test, not a deployed orbital data center. Google says it will next evaluate the TPU under thermal stress and radiation exposure, then aims for twin interconnected satellites in 2027. The test demonstrates a functioning inference loop on this prototype; it does not answer the cost, reliability, launch or scaling questions required for practical space-based compute.

A randomized study tests structured AI visit preparation

A preprint posted October 30 reports a prospective, consented randomized study of an LLM-based agent designed to help people prepare for clinical visits. The researchers studied 802 U.S. adults across 866 health-related conversations in the Google Health app, comparing structured and concise agent variants with a minimally prompted control chatbot built on the same model.

The paper reports higher blinded clinician ratings for comprehensive preparation and better patient-reported preparedness for the structured agent. It also says clinician and participant measures were not significantly correlated, a useful reminder that different evaluation methods can capture different things. The work is a preprint, and its findings concern visit preparation rather than diagnosis or treatment; it should not be read as proof that general-purpose chatbots are safe substitutes for clinicians.